SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. (not Streamex Corp.) on April 28, 2025, reporting events occurring on April 24, 2025. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. The report focuses exclusively on a specific equity issuance event.
Material Changes
On April 24, 2025, the Company issued 2,750,000 restricted shares of common stock (Provider Shares) to certain service providers. These shares were issued in consideration for business development services. The issuance was not registered under the Securities Act of 1933 and relied on the Section 4(a)(2) exemption.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of general risks and contingencies beyond the specific details of the unregistered securities sale.
Investor Verification Checklist
- Verify the valuation of the business development services received in exchange for the 2,750,000 shares.
- Confirm the dilution impact of this issuance on existing shareholders.
- Review the specific terms and restrictions attached to the Provider Shares.
- Check for any related party transactions involving the service providers.